Isis Innovation, Oxford’s research and technology commercialisation company, is winning record early stage funding for its latest projects. Read about some of their exciting new companies.

getrewardsgetbountsOne of the projects is Boutns, which offers 'airmiles for exercise'
 
Thirty five Oxford projects received £4.6 million in funding from proof-of-concept and seed funds managed by Isis Innovation in the last financial year. As part of this ongoing success, the third University of Oxford Isis Fund (UOIF III) has now opened to investors.

“Oxford alumni have been enthusiastic investors in the first two UOIF funds, which raised £1.25m and £2.15m respectively,” said Isis Innovation Head of New Venture Support and Funding, Andrea Alunni. “The UOIF funds provide an opportunity to invest in a pipeline of the brightest Oxford technologies through a straightforward and tax-efficient vehicle under the SEIS/EIS regime. They are managed by Parkwalk Advisors with Isis Innovation as the portfolio advisor.”

“Early funding is vital to bring ideas developed at Oxford to life,” said Linda Naylor, managing director of Isis Innovation, “Such a large increase in seed and proof-of-concept funding bodes extremely well for innovation and academic entrepreneurship here at Oxford.” 
·         Bounts, which offers “airmiles for exercise” has tripled the number of members earning Bounts points to 3 million and has inked deals with a number of new b2b partners.  Bounts has been able to soft launch its points-based rewards system in the
Stroke-diagnostic specialist Brainomix has released its diagnostic software, which is being used in UK hospitals to detect strokes accurately and quickly
 
The University of Oxford Isis Funds I and II invested approximately £3m into 15 ventures. Its most recent investment was in machine learning spinout, Mind Foundry. In addition, The Oxford Invention Fund and the University Challenge Seed Fund provided £1.6 million in proof-of-concept funding to 23 early-stage projects. On the back of this proof of concept funding, 55 companies have been formed.

“We have also been able to support Oxford researchers in securing over £25m in translational funding during 2014 and 2015,” said Naylor. 
“Translational, seed and proof of concept funding is absolutely essential to bridge the gap between research grants and commercial investment. It enables our teams to build prototypes, run pre-clinical trials and gather essential supporting data.”
e-ASPECTS 
Some of the companies which received investment from the University of Oxford Isis Funds are:
·         Stroke-diagnostic specialist Brainomix has released its diagnostic software, which is being used in UK hospitals to detect strokes accurately and quickly. Within the next 12 months Brainomix plans to launch the product in Europe, the US and Brazil.
·         Sentiment analysis company TheySay is building its customer base through both direct sales and partnerships. Current customers include financial PR platforms, informatics, marketing service providers, hedge funds and equities derivatives brokers.
·         Medical device company Oxtex is planning to manufacture its self-inflating tissue expander for use in reconstructive surgery, burns and scar surgery, cleft palates, and in the veterinary market. The Oxtex has conducted two successful clinical trials in animals, and is soon to launch the product in this market. Human clinical trials are also being scheduled.
·         Bounts, which offers “airmiles for exercise” has tripled the number of members earning Bounts points to 3 million and has signed deals with new b2b partners.  Bounts has soft launched its points-based rewards system in the USA, Canada and India.
 
Alumni interested in participating in The University of Oxford Isis Fund III (UOIF III) or receiving more information can contact Parkwalk Advisors on 020 7759 2285; UOIF@parkwalkadvisors.com or Andrea Alunni at Isis Innovation (andrea.alunni@innovation.ox.ac.uk).
 
Images: Isis Innovations

Comments

By Jeremy Cohn
on

Beware all non-UK alumni: the fund managers will not allow you to invest.

By Michael A.
on

Has OxReach (on Hubbub.net), the University's new crowdfunding platform, featured in Oxford Today yet? It's first project is LIFE -- developing Live-saving Instructions for Emergencies in order to save the lives of newborns and mothers in Africa. Help Professor Mike English reduce infant mortality in Africa. LIFE is close to their £60,000 minimum target, can you help them reach it? Support LIFE by visiting https://spsr.me/yfUM

Add new comment